The cytokine response to strenuous exercise

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 5, 1998, Pages 505-511

  Pedersen, Bente Klarlund ^a,b   Ostrowski, Kenneth ^a   Rohde, Thomas ^a   Bruunsgaard, Helle ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Cytokines; Exercise; Interleukin; Muscle; Sepsis; Sport; Trauma

Indexed keywords

CREATINE KINASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; BACTERIAL INFECTION; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENDOTOXEMIA; EXERCISE; INJURY; MUSCLE BIOPSY; MUSCLE INJURY; MYALGIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEPSIS; SKELETAL MUSCLE; SPORT;

EID: 0031738805     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y98-055     Document Type: Conference Paper

References (56)

1. Bagby, G.J., Crouch, L.D., and Shepherd, R.E. 1996. Exercise and cytokines: spontaneous and elicited response. In Exercise and immune function. Edited by L. Hoffman-Goetz. CRC Press, New York. pp. 55-78.
2. Beutler, B., and Cerami, A. 1989. The biology of cachectin/TNF -a primary mediator of the host response. Annu. Rev. Immunol. 7.
3. Brock Utne, J.G., Gaffin, S.L., Wells, M.T., Gathiram, P., Sohar, E., James, M.F., Morrell, D.F., and Norman, R.J. 1988. Endotoxaemia in exhausted runners after a long-distance race. S. Afr. Med. J. 73: 533-536.
4. Bruunsgaard, H., Galbo, H., Halkjaer-Kristensen, J., Johansen, T.L., MacLean, D.A., and Pedersen, B.K. 1997. Exercise-induced increase in interleukin-6 is related to muscle damage. J. Physiol. (London), 499: 833-841.
5. Cannon, J.G., and Kluger, M.J. 1983. Endogenous pyrogen activity in human plasma after exercise. Science (Washington, D.C.), 220: 617-619.
6. Cannon, J.G., Evans, W.J., Hughes, V.A., Meredith, C.N., and Dinarello, C.A. 1986. Physiological mechanisms contributing to increased interleukin-1 secretion. J. Appl. Physiol. 61: 1869-1874.
7. Cannon, J.G., Fielding, R.A., Fiatarone, M.A., Orencole, S.F., Dinarello, C.A., and Evans, W.J. 1989. Increased interleukin 1 beta in human skeletal muscle after exercise. Am. J. Physiol. 257: R451-R455.
8. Cannon, J.G., Meydani, S.N., Fielding, R.A., Fiatarone, M.A., Meydani, M., Farhangmehr, M., Orencole, S.F., Blumberg, J.B., and Evans, W.J. 1991. Acute phase response in exercise. II. Associations between vitamin E, cytokines, and muscle proteolysis. Am. J. Physiol. 260: R1235-R1240.
9. Castell, L.M., Poortmans, J.R., Leclercq, R., Brasseur, M., Duchateau, J., and Newsholme, E.A. 1997. Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation. Eur. J. Appl. Physiol. 75: 47-53.
10. Clowes, G.H., Jr., George, B.C., Villee, B.C., Jr., and Saravis, C.A. 1983. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N. Engl. J. Med. 308: 545-552.
11. de Vries, H.E., Hoogendoorn, K.H., van Dijk, J., Zijlstra, F.J., van Dam, A.M., Breimer, D.D., van Berkel, T.J., de Boer, A.G., and Kuiper, J. 1995. Eicosanoid production by rat cerebral endothelial cells: stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. J. Neuroimmunol. 59: 1-8.
12. Dejana, E., Bertocchi, F. Bortolami, M.C., Regonesi, A., Tonta, A., Breviario, F., and Giavazzi, R. 1988. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J. Clin. Invest. 82: 1466-1470.
13. Dinarello, C.A. 1988. Biology of interleukin-1. FASEB J. 2: 108.
14. Dinarello, C.A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood, 77: 1627-1652.
15. Dinarello, C.A. 1992. Role of interleukin-1 in infectious diseases. Immunol. Rev. 127.
16. Dinarello, C.A., and Wolff, S.M. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328: 106-113. (published correction appears in 1993 N. Engl. J. Med. 328: 744.)
17. Dinarello, C.A., and Wolff, S.M. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328: 106-113. (published correction appears in 1993 N. Engl. J. Med. 328: 744.)
18. Dripps, D.J., Brandhuber, B.J., Thompson, R.C., and Eisenberg, S.P. 1991. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem. 266: 10 331-10 336.
19. DuBose, D.A., Basamania, K., Maglione, L., and Rowlands, J. 1983. Role of bacterial endotoxins of intestinal origin in rat heat stress mortality. J. Appl. Physiol. 54: 31-36.
20. Eisenberg, S.P., Evans, R.J., Arend, W.P., Verderber, E., Brewer, M.T., Hannum, C.H., and Thompson, R.C. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature (London), 343: 341-346.
21. Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y.S., Sarov, I., Nophar, Y., Hadas, E., Leitner, O., and Wallach, D. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265: 14 497-14 504.
22. Espersen, G.T., Elbaek, A., Ernst, E., Toft, E., Kaalund, S., Jersild, C., and Grunnet, N. 1990. Effect of physical exercise on cytokines and lymphocyte subpopulations in human peripheral blood. APMIS, 98: 395-400.
23. Evans, W.J., Meredith, C.N., Cannon, J.G., Dinarello, C.A., Frontera, W.R., Hughes, V.A., Jones, B.H., and Knuttgen, H.G. 1986. Metabolic changes following eccentric exercise in trained and untrained men. J. Appl. Physiol. 61: 1864-1868.
24. Flores, E.A., Bistrian, B.R., Pomposelli, J.J., Dinarello, C.A., Blackburn, G.L., and Istfan, N.W. 1989. Infusion of tumor necrosis factor/cachectin promotes muscle metabolism in the rat. A synergistic effect with interleukin 1. J. Clin. Invest. 83: 1614-1622.
25. Goldberg, A.L., Kettelhut, I.C., Furuno, K., Fagan, J.M., and Baracos, V. 1988. Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines. J. Clin. Invest. 81: 1378-1383.
26. Granowitz, E.V., Clark, B.D., Mancilla, J., and Dinarello, C.A. 1991. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J. Biol. Chem. 266: 14 147-14 150.
27. Hannum, C.H., Wilcox, C.J., Arend, W.P., Joslin, F.G., Dripps, D.J., Heimdal, P.L., Armes, L.G., Sommer, A., Eisenberg, S.P., and Thompson, R.C. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (London), 343: 336-340.
28. Homburger F. 1945. A plasma fibronogen-increasing factor obtained from sterile abscesses in dogs. J. Clin. Invest. 24: 43-45.
29. Kampschmidt, R.F., and Upchurch, H.F. 1974. Effect of leucocytic endogenous mediator on plasma fibrinogen and haptoglobin. Proc. Soc. Exp. Biol. Med. 146: 904-907.
30. Loetscher, H., Pan, Y.C., Lahm, H.W., Gentz, R., Brockhaus, M., Tabuchi, H., and Lesslauer, W. 1990. Molecular cloning and expression of the human 55 kDa tumor necrosis factor receptor. Cell, 61: 351-359.
31. Mazzei, G.J., Seckinger, P.L., Dayer, J.M., and Shaw, A.R. 1990. Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1. Eur. J. Immunol. 20: 683-689.
32. Moldawer, L.L., Svaninger, G., Gelin, J., and Lundholm, K.G. 1987. Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am. J. Physiol. 253: C766-C773.
33. Moore, G.E., Holbein, M.E., and Knochel, J.P. 1995. Exercise-associated collapse in cyclists is unrelated to endotoxemia. Med. Sci. Sports Exercise. 27: 1238-1242.
34. Nawabi, M.D., Block, K.P., Chakrabarti, M.C., and Buse, M.G. 1990. Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. J. Clin. Invest. 85: 256-263.
35. Northoff, H., and Berg, A. 1991. Immunologic mediators as parameters of the reaction to strenuous exercise. Int. J. Sports Med. 12: S9-S15.
36. Ostrowski, K., Rohde, T., Zacho, M., Asp, S., and Pedersen, B.K. 1998. Evidence that IL-6 is produced in skeletal muscle during intense long-term muscular activity. J. Physiol. (London), 508: 949-953.
37. Richards, C., and Gauldie, J. 1995. Role of cytokines in acute-phase response. In Human cytokines: their roles in disease and therapy. Edited by B.B. Aggarwal and R.K. Puri. Blackwell Science, Cambridge, Mass. pp. 253-269.
38. Rivier, A., Pene, J., Chanez, P., Anselme, F., Caillaud, C., Prefaut, C., Godard, P., and Bousquet, J. 1994 Release of cytokines by blood monocytes during strenuous exercise. Int. J. Sports Med. 15: 192-198.
39. Rohde, T., MacLean, D.A., Richter, E.A., Kiens, B., and Pedersen, B.K. 1997. Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6. Endocrinol. Metab. 36: E85-E91.
40. Rosenberg, A.T., Brock Utne, J.G., Gaffin, S.L., Wells, M.T., and Blake, G.T. 1988. Strenuous exercise causes systemic endotoxemia. J. Appl. Physiol. 65: 106-108.
41. Sandri, M., Carraro, U., Podhorska-Okolov, M., Rizzi, C., Arslan, P., Monti, D., and Franceschi, C. 1995. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett. 373: 291-295.
42. Seckinger, P., Lowenthal, J.W., Williamson, K., Dayer, J.M., and MacDonald, H.R. 1987. A urine inhibitor of interleukin 1 activity that blocks ligand binding. J. Immunol. 139: 1546-1549.
43. Smith, C.A., Davis, T., Anderson, D., Solam, L., Beckmann, M.P., Jerzy, R., Dower, S.K., Cosman, D., and Goodwin, R.G. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science (Washington, D.C.), 248: 1019-1023.
44. Smith, J.A., McKenzie, S.J., Telford, R.D., and Weidemann, M.J. 1992. Why does moderate exercise enhance, but intense training depress, immunity? In Behavior and immunity. Husband. pp. 155-168.
45. Smith, L.L. 1991. Acute inflammation: the underlying mechanism in delayed onset muscle soreness? Med. Sci. Sports Exercise, 23: 542-551.
46. Snell, E.S., and Atkins, E. 1965. The presence of endogenous pyrogen in normal rabbit tissue. J. Exp. Med. 121: 1019-1038.
47. Sprenger, H., Jacobs, C., Nain, M., Gressner, A.M., Prinz, H., Wesemann, W., and Gemsa, D. 1992. Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin. Immunol. Immunopathol. 63: 188-195.
48. Strassmann, G., Patil Koota, V., Finkelman, F., Fong, M., and Kambayashi, T. 1994. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180: 2365-2370.
49. Taga, T., and Kishimoto, T. 1992. Cytokine receptors and signal transduction. FASEB J. 6: 3387-3396.
50. Tartaglia, L.A., Pennica, D., and Goeddel, D.V. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268: 18542-18548.
51. Tewari, A., Buhles, W.C., Jr., and Starnes, H.F., Jr. 1990. Preliminary report: effects of interleukin-1 on platelet counts. Lancet, 336: 712-714. (Retracted in 1992 by W.C. Buhles, and H.F. Starnes. Lancet, 340: 496.)
52. Tewari, A., Buhles, W.C., Jr., and Starnes, H.F., Jr. 1990. Preliminary report: effects of interleukin-1 on platelet counts. Lancet, 336: 712-714. (Retracted in 1992 by W.C. Buhles, and H.F. Starnes. Lancet, 340: 496.)
53. Ullum, H., Haahr, P.M., Diamant, M., Palmo, J., Halkjaer Kristensen, J., and Pedersen, B.K. 1994a. Bicycle exercise enhances plasma IL-6 but does not change IL-1, IL-1, IL-6, or TNF-pre-mRNA in BMNC. J. Appl. Physiol. 77: 93-97.
54. Ullum, H., Palmo, J., Halkjaer Kristensen, J., Diamant, M., Klokker, M., Kruuse, A., LaPerriere, A., and Pedersen, B.K. 1994b. The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive persons. J. Acquired Immune Defic. Syndr. 7: 1122-1133.
55. Vilcek, J., and Lee, T.H. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266: 7313-7316.
56. Waage, A., Halstensen, A., Shalaby, R., Brandtæg, P., Kierullf, P., and Espevik, T. 1989. Local production of tumour necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. J. Exp. Med. 170: 1859-1867.